sk 609

SK609 is a selective dopamine D3 receptor agonist which significantly improves the performance of the impaired paw and normalizes the bilateral asymmetry associated with the hemiparkinson rat.

ACT-672125 is a Potent CXCR3 Antagonist with Therapeutic Potential in Autoimmune Diseases. ACT-672125 showed good physicochemical properties and safety profile. In a proof-of-mechanism model of lung inflammation, ACT-672125 inhibited the recruitment of CXCR3 expressing T cells into the inflamed lung in a dose-dependent manner.

SK609 HCl (SK609 hydrochloride) 是一种多巴胺 D3 受体 (D3R) 选择性激动剂，抑制去甲肾上腺素转运蛋白，可用于研究帕金森病和认知障碍。